ERBB2 and breast cancer: Furthermore, an analysis of human data from The Cancer Genome Atlas (TCGA) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) demonstrated a significant correlation between elevated VMP1 levels and shorter survival periods in Receptor Protein-Tyrosine Kinase (HER2)-positive breast cancer.